Second NICU and Neonatology Department, Aristotle University of Thessaloniki, GPN Papageorgiou, Ring Road Nea Efkarpia, 56403 Thessaloniki, Greece.
Indian Pediatr. 2011 Aug;48(8):601-5. doi: 10.1007/s13312-011-0104-z. Epub 2010 Nov 30.
This study reports our institutional experience on the outcome after prophylactic and early rescue endotracheal instillation of surfactant within 20 minutes of birth, followed by extubation and nasal continuous positive airway pressure (NCPAP) in preterm infants <32 weeks gestational age.
A total of 142 infants were prospectively studied (42, gestational age from 23 to 27 and 100, from 28 up to 32 weeks). All infants were electively intubated for administration of 200 mg/kg porcine isolated surfactant (Curosurf, Chiesi Farmaceutici SPA, Parma, Italy) as soon as practicably possible (within 20 min after birth) and NCPAP was then initiated.
Extubation and switch to NCPAP at 6 h was successful in 6/42 (14.3%) infants less than 28 weeks gestational age and 75/100 (75%) infants 28-32 weeks gestational age. Out of 81 infants that were successfully extubated, 76 (93.83%) never required re-ventilation. At 96 h of age, need for continuing intubation and ventilation was required by 6/38 (15.8%) alive infants <28 weeks gestational age and 8/100 (8%) infants 28-32 weeks gestational age. Mean duration of NCPAP post-extubation was 38±20 hours for infants 23-27 wks and 29±15 hours for infants 28-32 wks gestational age. The mortality rate was 2.81% (4/142).
Implementation of prophylactic or early rescue administration of surfactant with NCPAP in infants at high risk for developing RDS in neonatal ICU is a safe modality of respiratory support in preterm infants.
本研究报告了我们机构在早产儿 <32 周胎龄时,出生后 20 分钟内预防性和早期挽救性气管内滴注表面活性剂,然后拔管并给予鼻塞持续气道正压通气(NCPAP)的经验,观察其结局。
共有 142 例婴儿进行了前瞻性研究(42 例,胎龄 23-27 周;100 例,胎龄 28-32 周)。所有婴儿均为选择性插管,以便尽快(出生后 20 分钟内)给予 200mg/kg 猪源性分离表面活性剂(Curosurf,Chiesi Farmaceutici SPA,Parma,意大利),然后开始给予 NCPAP。
胎龄<28 周的 6/42(14.3%)例和胎龄 28-32 周的 75/100(75%)例婴儿在 6 小时时成功拔管并转换为 NCPAP。81 例成功拔管的婴儿中,76 例(93.83%)从未需要再次通气。在 96 小时龄时,胎龄<28 周的存活婴儿中,有 6/38(15.8%)例需要继续插管和通气,胎龄 28-32 周的婴儿中,有 8/100(8%)例需要继续插管和通气。胎龄 23-27 周的婴儿拔管后 NCPAP 的平均持续时间为 38±20 小时,胎龄 28-32 周的婴儿为 29±15 小时。死亡率为 2.81%(4/142)。
在新生儿重症监护病房(NICU)中,对有发生 RDS 风险的婴儿预防性或早期挽救性给予表面活性剂联合 NCPAP,是一种对早产儿安全的呼吸支持方式。